Understanding how congenital cytomegalovirus affects infant development and maternal experiences
Congenital cytomegalovirus: Infant developmental trajectories and parent experiences
This study is looking at how babies born with congenital cytomegalovirus (cCMV) grow and develop in their first year, while also exploring how their moms' stress and coping skills might affect their progress, so we can find better ways to support both moms and their little ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10908435 on NIH RePORTER |
What this research studies
This research investigates the developmental trajectories of infants born with congenital cytomegalovirus (cCMV) and how maternal stress and coping skills influence these outcomes. By following a cohort of 100 mother-infant pairs over the first year of life, the study aims to identify specific developmental challenges and the psychosocial factors that may impact these infants. The research will gather data on infant development and maternal experiences to create targeted interventions that can improve outcomes for both mothers and their children. This approach emphasizes the importance of both biological and environmental factors in shaping developmental progress.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants diagnosed with congenital cytomegalovirus and their mothers.
Not a fit: Patients who do not have congenital cytomegalovirus or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved support and interventions for infants with cCMV and their mothers, enhancing developmental outcomes.
How similar studies have performed: Previous research has shown that understanding psychosocial factors can significantly improve developmental outcomes in at-risk populations, suggesting this approach may be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Pesch, Megan H. — University of Michigan at Ann Arbor
- Study coordinator: Pesch, Megan H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.